ABIO | ARCA biopharma Inc 4.25 -0.07 (-1.58%)
Category: Consumer goods
Quick infos Headquarters: Westminster, Colorado, United States Trade prices Volume: Market Cap: 38.68M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 12, 2021
Earnings History Date EPS / Forecast Revenue / Forecast May 12, 2021 March 24, 2021 - / -2.44- / -November 2, 2020 -0.33 / -2.51- / -August 5, 2020 -0.73 / -2.58- / -May 6, 2020 -0.83 / -2.04- / -view more
Historical Data Date Price Open High Low Vol Change ER Mar 22, 2021 4.26 4.24 4.34
4.19
805.25K 1.91% Mar 19, 2021 4.18 4.03 4.34
3.92
1.46M 2.96% Mar 18, 2021 4.06 4.09 4.26
4.05
310.33K -2.17% Mar 17, 2021 4.15 4.08 4.21
3.94
747.42K -1.43% Mar 16, 2021 4.21 4.33 4.34
4.10
603.31K -2.32% Mar 15, 2021 4.31 4.30 4.34
4.23
491.43K 0.94% Mar 12, 2021 4.27 4.24 4.33
4.16
466.23K -0.93% Mar 11, 2021 4.31 4.14 4.35
4.12
665.20K 4.61% Mar 10, 2021 4.12 4.13 4.17
4.02
424.51K 1.48% Mar 9, 2021 4.06 4.03 4.16
4.00
1.30M 2.01% view more
News
ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update finance.yahoo.com Oct 15, 2020 4:30 pm
Price Over Earnings Overview: ARCA biopharma finance.yahoo.com Oct 15, 2020 10:27 am
Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More finance.yahoo.com Oct 15, 2020 9:56 am
ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial finance.yahoo.com Oct 15, 2020 8:30 am
Anders Hove, MD Joins ARCA biopharma Board of Directors finance.yahoo.com Oct 15, 2020 8:30 am
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation finance.yahoo.com Oct 15, 2020 8:30 am
Free Technical Insights on Aimmune Therapeutics and Three More Biotech Stocks finance.yahoo.com Oct 15, 2020 7:15 am
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19 finance.yahoo.com Oct 7, 2020 8:30 am
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19 finance.yahoo.com Sep 21, 2020 9:09 am
ARCA Biopharma Submits IND Application To FDA For AB201 As Potential COVID-19 Treatment nasdaq.com Sep 21, 2020 9:09 am ARCA Biopharma files to commence AB201 study for COVID-19 seekingalpha.com Sep 21, 2020 9:09 am ARCA biopharma, Inc. (NASDAQ:ABIO) Files An 8-K Entry into a Material Definitive Agreement marketwatch.com Sep 1, 2020 9:09 am
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth finance.yahoo.com Aug 17, 2020 9:08 am VBL Therapeutics' Cancer Drug, And Other News: The Good, Bad And Ugly Of Biopharma seekingalpha.com Aug 13, 2020 7:08 pm
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19 finance.yahoo.com Aug 12, 2020 12:08 pm ARCA biopharma readies mid-stage study of AB201 in COVID-19 seekingalpha.com Aug 12, 2020 12:08 pm Talk about ARCA biopharma Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
